Understanding your genetic and metabolic context can support a more informed conversation with your provider about whether GLP-1 alone is appropriate for your situation, what dosing and formulation might be most suitable, and whether exercise integration is medically feasible or beneficial for your particular health profile
Glycemic improvements often precede significant weight changes, and individual responses vary based on baseline metabolic status, dosing regimen, and adherence to lifestyle modifications
What youll learn: High costs and uncomfortable side effects of traditional GLP-1 medications lead many people to stop using them
A GLP-1 receptor agonist mimics a hormone naturally produced in the gut
Semaglutide 2.4 mg (Wegovy) showed approximately 15% weight loss at 68 weeks, while tirzepatide (Zepbound) demonstrated up to 21% at 72 weeks, and liraglutide 3 mg (Saxenda) about 5-8%
Is this just another case of media hysteria, or is there really something to be concerned about